FDA says Moderna's Covid vaccine is effective, safe for young children
The FDA said Moderna's Covid vaccine for children 6 months to 17 years old is safe and effective. An advisory committee will meet next week to vote on the vaccines.
U.S. Food and Drug Administration staff reviewers on Friday said Moderna's Covid-19 vaccine appears safe and effective for use in children aged 6 months to 17 years old as a committee of scientists will meet next week to vote on whether to recommend the regulator authorize the vaccine in children.
The FDA’s reviewers said in briefing documents published on Friday evening that the vaccine had generated a similar immune response in the children than that observed in adults in previous trials.
Full coverage of the Covid-19 pandemic
“Available data support the effectiveness of the Moderna Covid-19 Vaccine in preventing symptomatic Covid-19 in pediatric age groups from 6 months through 17 years of age,” the FDA staff said.
The FDA staff also said the vaccine generally had a similar side effect profile in children as seen in adults, although younger children had fevers more frequently.
Rating: 5